Ingrid Ramirez Diaz
Gynecologic Oncology · Ponce, PRNPI 1194987552
Payments from drug & device makers
What this record shows
This record is dominated by education: $20,000 of the $29,272 with a category attached, or 68.3%. Intuitive Surgical accounts for 80.8% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $12,033, more than ten times the $100 reported in 2019.
Across 129 payments — averaging $226.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$24K
- Merck$3K
- AstraZeneca$930
- AbbVie$222
- GSK$185
- Hologic Sales And Service, LLC$163
- plus $726 from 12 others
What the payments were for
- Consulting fees$1,9006%
- Speaking & faculty fees$1,1254%
- Travel & lodging$2,5359%
- Food & beverage$3,71213%
- Education$20,00068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 31 | $23,659 |
| Merck | 20 | $3,387 |
| AstraZeneca | 36 | $930 |
| AbbVie | 6 | $222 |
| GSK | 8 | $185 |
| Hologic Sales And Service, LLC | 6 | $163 |
| Eisai Inc. | 2 | $149 |
| Pfizer | 7 | $141 |
| BD | 1 | $102 |
| Johnson And Johnson International | 1 | $100 |
| Seagen Inc. | 3 | $58 |
| Stryker | 1 | $48 |
| Tempus AI, Inc | 2 | $30 |
| Caris MPI, Inc. | 1 | $25 |
| Clovis Oncology, Inc. | 1 | $22 |
| Fennec Pharmaceuticals, Inc. | 1 | $18 |
| Immunogen, Inc. | 1 | $17 |
| PBG Puerto Rico LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$21,877
- KEYTRUDA$3,025
- DAVINCI XI$1,000
- LENVIMA$125
- Elahere$122
- BD ONCLARITY$102
- ENSEAL Product Family$100
How this compares
Too few gynecologic oncology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LynparzaOlaparib | 22 | $187,141 |
| Ondansetron Hcl | 46 | $953 |
| Estradiol | 17 | $848 |
| Famotidine | 60 | $524 |
| Clobetasol Propionate | 11 | $524 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 32 | $474 |
| Metoclopramide Hcl | 45 | $342 |
| Gabapentin | 14 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLynparza | $930 | $187,14122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecologic oncology providers in Puerto Ricoon file to place this against a meaningful peer group, so we don't.
Other gynecologic oncology in Ponce
- Ricardo Gomez-MartinezPonce$371
- Micael Lopez-AcevedoManati$161K
- Luis Santos ReyesHato Rey$29K
- Pedro Escobar RodriguezSan Juan$21K
- Fiorella Reyes BaezSan Juan$4K
- Edward HernandezGuayama$3K
- Nicole Lugo SantiagoSan Juan$2K
- Sharee UmpierreSan Juan$22
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.